These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3273621)

  • 1. Pertussis vaccine acceptance rates and incidence of pertussis in forty seven districts (prefectures) in Japan since 1977.
    Kimura M; Kuno-Sakai H; Ozaki K
    Tokai J Exp Clin Med; 1988; 13 Suppl():9-13. PubMed ID: 3273621
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of pertussis in Japan.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():1-7. PubMed ID: 3273609
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of acellular pertussis vaccine in Japan--comparison of two areas, one area where immunization started at 6 months and the other area at over 2 years of age--Regional Surveillance Committee on Tuberculosis and Infectious Diseases of Osaka.
    Ohkuni H; Kitaura T; Tamai T; Takasugi Y; Sugimoto T; Fukai K
    Tokai J Exp Clin Med; 1988; 13 Suppl():51-4. PubMed ID: 3273619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children hospitalised with pertussis in the Bay of Plenty.
    Jarman JN
    N Z Med J; 1992 Aug; 105(940):340. PubMed ID: 1508453
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of currently available Japanese acellular pertussis vaccines and future problems.
    Kamiya H; Nii R
    Tokai J Exp Clin Med; 1988; 13 Suppl():45-9. PubMed ID: 3273618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing epidemiology and emerging risk groups for pertussis.
    Galanis E; King AS; Varughese P; Halperin SA;
    CMAJ; 2006 Feb; 174(4):451-2. PubMed ID: 16477052
    [No Abstract]   [Full Text] [Related]  

  • 9. Pertussis outbreaks in the United States.
    Etkind P
    Am Fam Physician; 1991 Nov; 44(5):1622-3. PubMed ID: 1950959
    [No Abstract]   [Full Text] [Related]  

  • 10. Has the change to acellular pertussis vaccine improved or worsened pertussis control?
    Halperin SA; De Serres G
    CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis control in New Zealand.
    Reid S; Lennon D; Thomas M; O'Connor P; Baker M; Mansoor O
    N Z Med J; 1994 Nov; 107(989):460-2, 463-6. PubMed ID: 7970359
    [No Abstract]   [Full Text] [Related]  

  • 14. Japanese clinical experiences with acellular pertussis vaccines.
    Kimura M
    Dev Biol Stand; 1991; 73():5-9. PubMed ID: 1778333
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation on the basis of the rates of secondary attack of whooping cough in families of the vaccination and prophylactic efficacy of pertussis vaccine in 2 districts of the city of Bucharest].
    Ion-Nedelcu N; Mihăileanu C; Apetrei R; Velea L; Ulmeanu V; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(4):319-26. PubMed ID: 3255159
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis and pertussis vaccine in the industrialized world.
    Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():93-6. PubMed ID: 3273622
    [No Abstract]   [Full Text] [Related]  

  • 18. [An outbreak of pertussis].
    Marguet C; Mallet E
    Arch Fr Pediatr; 1990 Mar; 47(3):228. PubMed ID: 2344257
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
    Kato T; Kaku H; Arimoto Y
    Tokai J Exp Clin Med; 1988; 13 Suppl():35-8. PubMed ID: 3078808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis in Newfoundland and Labrador: 1991-2004.
    Can Commun Dis Rep; 2005 Nov; 31(22):235-7. PubMed ID: 16669124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.